We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
1001
DELISTED
Exact Sciences
EXAS
– –
-10,328
Closed -$436K
EXLS icon
1002
EXL Service
EXLS
$4.36B
– –
-6,609
Closed -$207K
AGNT
1003
AGNT Inc
AGNT
$690M
– –
-15,619
Closed -$176K
EXPO icon
1004
Exponent
EXPO
$3.04B
– –
-8,759
Closed -$833K
EZPW icon
1005
Ezcorp Inc
EZPW
$1.87B
– –
-19,029
Closed -$199K
FAF icon
1006
First American
FAF
$7.79B
– –
-6,536
Closed -$353K
FARO
1007
DELISTED
Faro Technologies
FARO
– –
-13,273
Closed -$212K
FCFS icon
1008
FirstCash
FCFS
$9.06B
– –
-4,504
Closed -$472K
FERG icon
1009
Ferguson
FERG
$45.4B
– –
-12,288
Closed -$2.38M
FIVE icon
1010
Five Below
FIVE
$11.5B
– –
-8,053
Closed -$878K
FLEX icon
1011
Flex
FLEX
$42.5B
– –
-17,842
Closed -$526K
FLGT icon
1012
Fulgent Genetics
FLGT
$556M
– –
-17,147
Closed -$336K
FORR icon
1013
Forrester Research
FORR
$185M
– –
-18,803
Closed -$321K
FSLR icon
1014
First Solar
FSLR
$22.1B
– –
-3,296
Closed -$743K
FSV icon
1015
FirstService
FSV
$6.45B
– –
-2,807
Closed -$428K
FTDR icon
1016
Frontdoor
FTDR
$5.1B
– –
-15,521
Closed -$524K
FTI icon
1017
TechnipFMC
FTI
$29.9B
– –
-7,890
Closed -$206K
FTNT icon
1018
Fortinet
FTNT
$112B
– –
-12,291
Closed -$741K
FTRE icon
1019
Fortrea Holdings
FTRE
$1.82B
– –
-36,603
Closed -$854K
FTV icon
1020
Fortive
FTV
$19.2B
– –
-9,067
Closed -$506K
FWONK icon
1021
Liberty Media Series C
FWONK
$24.6B
– –
-6,089
Closed -$437K
FWRD icon
1022
Forward Air
FWRD
$466M
– –
-36,759
Closed -$700K
GD icon
1023
General Dynamics
GD
$105B
– –
-9,708
Closed -$2.82M
GDEN
1024
DELISTED
Golden Entertainment
GDEN
– –
-11,213
Closed -$349K
GENI icon
1025
Genius Sports
GENI
$1.94B
– –
-80,161
Closed -$437K
39 40
41
42 43

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.